Dashboard
Manage Tickers

ARYD ARYA Sciences Acquisition C...

Nasdaq adagiomedical.com


$ -2.32 (-25.92 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 633.20 $ -9.72 (-1.53 %)
DIA $ 475.83 $ -1.36 (-0.29 %)
SPY $ 684.43 $ -7.56 (-1.1 %)
TLT $ 90.42 $ -0.53 (-0.58 %)
GLD $ 371.67 $ 7.13 (1.96 %)
$ 6.64
-- x --
-- x --
-- - --
$ 6.25 - $ 11.57
94,462
na
9.81M
$ 0.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-20-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 04-06-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-06-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

adagio-medical-to-list-on-nasdaq-through-business-combination-with-spac-company-arya-sciences-acquisition-corp-iv
Adagio Medical To List On Nasdaq Through B...
02/14/2024 11:12:05

The Combined Company's common stock is expected to be listed on the Nasdaq Capital Market under the ticker symbol "ADGM...

arya-sciences-acquisition-iv-corp-announced-it-would-restate-the-financial-statements-included-in-the-quarterly-report-in-the-annual-report-on-form-10-k-for-the-year-ended-december-31-2022
ARYA Sciences Acquisition IV Corp Announce...
04/05/2023 11:16:31

https://www.sec.gov/ix?doc=/Archives/edgar/data/1838821/000114036123016524/brhc10050928_8k.htm

stocks-that-hit-52-week-lows-on-friday
Stocks That Hit 52-Week Lows On Friday
02/25/2022 15:41:24

  During Friday's trading, 54 companies set new 52-week lows.

gene-therapy-player-amicus-therapeutics-terminates-spac-merger-shares-fall
Gene Therapy Player Amicus Therapeutics Te...
02/24/2022 15:03:56

Amicus Therapeutics Inc (NASDAQ: FOLD) has terminated its plans to spin off its gene therapy assets, citing 'existing mar...

the-daily-biotech-pulse-orphazyme-plunges-on-regulatory-setback-in-europe-pulmonx-earnings-disappoint-amicus-declines-to-spin-off-genetic-medicine-company
The Daily Biotech Pulse: Orphazyme Plunges...
02/24/2022 13:01:21

Here's a roundup of top developments in the biotech space over the last 24 hours:

Core News & Articles
ARYA Sciences Acquisition Corp. IV, Amicus...
02/24/2022 12:03:45

ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) (“ARYA IV”), a publicly traded special purpose acquisition company sponsored by...

perceptive-advisors-backed-spac-to-acquire-amicuss-gene-therapy-business
Perceptive Advisors-Backed SPAC To Acquire...
09/29/2021 13:26:17

the-daily-biotech-pulse-abbvies-migraine-drug-okd-by-fda-amicus-spins-off-gene-therapy-business-geovax-in-licenses-cancer-drug
The Daily Biotech Pulse: AbbVie's Migraine...
09/29/2021 12:13:40

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga'...

Core News & Articles
Stocks That Hit 52-Week Lows On Tuesday
08/17/2021 14:12:34

    Tuesday morning, 282 companies set new 52-week lows.

arya-sciences-acquisition-corp-iv-shares-will-open-for-quote-at-1035-am-est-expected-to-open-for-trade-after-1045-am-est-ipo-priced-at-10unit
ARYA Sciences Acquisition Corp IV Shares W...
02/26/2021 14:06:56

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION